AJORA 2026 · Toxicités, soins de support et points de revue

Chargement des contenus AJORA 2026…

Case data stay on this device Case data are processed locally in this browser and are not transmitted to, stored by, or accessible to CarcinoLogica. Ordinary website technical data such as server logs or cookie-consent data are processed separately.

RT Prescription Navigator

European dose references and source comparison. Select a schedule to examine its indication and provenance.

Evidence-linked schedulesNo server-side case storagev0.4.19
How to useBrowse the table → click a setting to focus → select a schedule to review or transfer.
TNCD 2026 · biliary cancers Guideline reference

Intrahepatic cholangiocarcinoma: stereotactic RT may be discussed for lesions <5 cm without extrahepatic disease when surgery and percutaneous ablation are not possible (TNCD option, grade C).

Adjuvant treatment: chemoradiotherapy with capecitabine may be discussed after 4–6 months of adjuvant capecitabine for selected R1 perihilar/distal cholangiocarcinomas or gallbladder cancers (expert opinion).

Evidence: ABC-07 did not establish a PFS or OS benefit from adding SBRT to chemotherapy. Multidisciplinary review and organ-at-risk constraints remain essential; no dose prescription is inferred here.

TNCD chapter 8 · revision 28 September 2026 ↗
Select a schedule above to review its source, OAR information and handoff options.